DHG Pharmaceutical JSC (HOSE:DHG)
Vietnam
· Delayed Price · Currency is VND 100,000
+300 (0.30%)
At close: Apr 29, 2026
DHG Pharmaceutical JSC Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 13,035,383 | 13,375,323 | 13,584,517 | 13,597,591 | 11,100,341 | 14,774,306 | Upgrade
|
| Market Cap Growth | 11.27% | -1.54% | -0.10% | 22.50% | -24.87% | 8.65% | Upgrade
|
| Enterprise Value | 10,813,102 | 11,688,546 | 11,903,276 | 11,999,699 | 8,991,684 | 12,831,532 | Upgrade
|
| Last Close Price | 99700.00 | 102300.00 | 98046.48 | 88644.65 | 70141.05 | 90417.79 | Upgrade
|
| PE Ratio | 14.94 | 16.22 | 18.03 | 13.37 | 11.60 | 19.75 | Upgrade
|
| Forward PE | 12.87 | 13.41 | 13.08 | 10.98 | 11.70 | 17.65 | Upgrade
|
| PS Ratio | 2.47 | 2.54 | 2.78 | 2.71 | 2.37 | 3.69 | Upgrade
|
| PB Ratio | 2.93 | 3.23 | 3.32 | 2.80 | 2.59 | 3.90 | Upgrade
|
| P/TBV Ratio | 3.05 | 3.38 | 3.47 | 2.91 | 2.71 | 4.12 | Upgrade
|
| P/FCF Ratio | 15.88 | 11.32 | 11.05 | - | 16.64 | 34.53 | Upgrade
|
| P/OCF Ratio | 15.03 | 11.03 | 10.31 | 56.62 | 12.32 | 32.65 | Upgrade
|
| PEG Ratio | - | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | Upgrade
|
| EV/Sales Ratio | 2.05 | 2.22 | 2.44 | 2.39 | 1.92 | 3.21 | Upgrade
|
| EV/EBITDA Ratio | 9.70 | 10.92 | 10.92 | 10.52 | 7.77 | 13.60 | Upgrade
|
| EV/EBIT Ratio | 10.85 | 12.27 | 12.93 | 11.40 | 8.36 | 14.91 | Upgrade
|
| EV/FCF Ratio | 13.17 | 9.89 | 9.69 | - | 13.48 | 29.99 | Upgrade
|
| Debt / Equity Ratio | - | - | 0.16 | 0.12 | 0.03 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.60 | 0.50 | 0.10 | 0.22 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.53 | - | 0.17 | 0.49 | Upgrade
|
| Net Debt / Equity Ratio | -0.50 | -0.52 | -0.53 | -0.30 | -0.51 | -0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.99 | -2.01 | -1.98 | -1.30 | -1.89 | -1.92 | Upgrade
|
| Net Debt / FCF Ratio | -2.71 | -1.82 | -1.76 | 6.02 | -3.27 | -4.23 | Upgrade
|
| Asset Turnover | 0.96 | 0.95 | 0.81 | 0.89 | 0.96 | 0.88 | Upgrade
|
| Inventory Turnover | 2.47 | 2.58 | 2.07 | 1.92 | 2.08 | 2.19 | Upgrade
|
| Quick Ratio | 3.81 | 2.92 | 1.91 | 2.25 | 3.28 | 3.18 | Upgrade
|
| Current Ratio | 5.46 | 4.03 | 2.57 | 3.90 | 5.20 | 4.92 | Upgrade
|
| Return on Equity (ROE) | 20.49% | 20.71% | 17.41% | 22.98% | 24.45% | 21.09% | Upgrade
|
| Return on Assets (ROA) | 11.33% | 10.70% | 9.53% | 11.66% | 13.74% | 11.87% | Upgrade
|
| Return on Invested Capital (ROIC) | 41.09% | 41.99% | 29.86% | 34.82% | 47.31% | 41.63% | Upgrade
|
| Return on Capital Employed (ROCE) | 22.10% | 22.60% | 22.10% | 21.40% | 24.70% | 22.30% | Upgrade
|
| Earnings Yield | 6.70% | 6.37% | 5.73% | 7.73% | 8.91% | 5.26% | Upgrade
|
| FCF Yield | 6.30% | 8.84% | 9.05% | -1.81% | 6.01% | 2.90% | Upgrade
|
| Dividend Yield | 10.05% | - | 10.20% | 8.46% | 4.99% | 3.87% | Upgrade
|
| Payout Ratio | 86.99% | 153.39% | 125.89% | 43.55% | 46.30% | 67.29% | Upgrade
|
| Total Shareholder Return | 10.89% | - | 10.20% | 8.46% | 4.99% | 3.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.